ING4 and TLX3

  • Number of citations of the paper that reports this interaction (PMID 20211142)
  • 148
  • Data Source:
  • BioGRID (two hybrid)

ING4

TLX3

Gene Name inhibitor of growth family, member 4 T-cell leukemia homeobox 3
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 17 interactors: CDC34 EGLN1 EP300 HIST1H3A HIST3H3 HNRNPD HOXB9 JADE1 JADE2 KAT7 MSX1 MYC NAV2 RELA SUV39H1 TLX3 TP53 16 interactors: DENND4A GTF2A1L HIST1H2BJ HNRNPUL1 HOPX ING4 IRF9 LMO2 MEIS1 PPP1CC PQBP1 SNTA1 SP1 TLE1 TLE2 ZNF41
Entrez ID 51147 30012
HPRD ID 09774 06868
Ensembl ID ENSG00000111653 ENSG00000164438
Uniprot IDs Q9UNL4 O43711
PDB IDs 2K1J 2M1R 2PNX 2VNF 4AFL
Enriched GO Terms of Interacting Partners?
Tagcloud ?
aad  adenovirus  adopted  apparently  arrested  bax  bcl  blot  caspase  cleaved  cne  differential  efect  g2  measure  mtt  nasopharyngeal  obviously  overexpressed  p21  pe  probable  regulating  rgd  rt  survivin  synergies  vector  western 
abt  alls  asparaginase  attractive  bcl  bh3  challenge  chemotherapeutic  correspondence  decreases  dexamethasone  doxorubicin  driven  exploited  gradually  highlights  hoxa  immature  intensified  loucy  lymphoblastic  mimetic  mostly  precursors  refractory  shows  subtypes  synergistic  tal1 
Tagcloud (Difference) ?
aad  adenovirus  adopted  apparently  arrested  bax  blot  caspase  cleaved  cne  differential  efect  g2  measure  mtt  nasopharyngeal  obviously  overexpressed  p21  pe  probable  regulating  rgd  rt  survivin  synergies  vector  western 
abt  alls  asparaginase  attractive  bh3  challenge  chemotherapeutic  correspondence  decreases  dexamethasone  doxorubicin  driven  exploited  gradually  highlights  hoxa  immature  intensified  loucy  lymphoblastic  mimetic  mostly  precursors  refractory  shows  subtypes  synergistic  tal1 
Tagcloud (Intersection) ?
bcl